Dave Fornell, DAIC Editor

Dave Fornell, Editor DAIC

Blog | Dave Fornell, DAIC Editor | June 06, 2013

New Trends and Technology in Electrophysiology from HRS 2013

The Heart Rhythm Society (HRS) 2013 scientific sessions covered the latest research and technology in electrophysiology (EP). Here are a few trends and innovative new technologies I wanted to highlight from the meeting.
 
One of the most innovative technologies discussed at the meeting was the Nanostim leadless pacemaker. The tiny device, about the size of a tip of a pen, is implanted via catheter inside the heart, attached to the wall of the left ventricular apex.
 
A new trend in transcatheter ablation technology has been the development of force sensing catheter tips to let operators know if they are applying enough force to guarantee proper lesions to improve patient outcomes. Companies with these technologies at HRS this year included nContactBiosense Webster and Endosense.
 
Another technology advancement to improve catheter ablations are new electro-anatomic mapping techniques. A large amount of interest was shown in the new AF FIRM rotor mapping technique, which offered positive data in trials, but also has spurred debate. It is believed by some that AF rotors move. If they are stationary, the ablations can be very successful, but if they move, relief from AF might only be temporary following a FIRM procedure.
 
Another new technology that generated interest at the show was Boston Scientific's new Rhythmia Mapping System, a 3-D mapping and navigation system, which will offer competition to the two existing systems on the market.
 
 

Related Content

Sponsored Content | Videos | Inventory Management| September 21, 2016
With bundled payments putting increased pressure on hospitals to manage supply costs while providing quality patient
Medtronic, CRT, cardiac resynchroniazation therapy devices, heart failure, medication adherence, retrospective analysis, HFSA 2016
News | Heart Failure| September 20, 2016
Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to heart failure...
don woodlock, GE Healthcare, EP CVIS, electrophyiology
Sponsored Content | Webinar | Cardiac PACS| September 16, 2016
Cardiac rhythm management (CRM) data is becoming increasingly important in the management of patients with implantabl
EBR Systems, FDA, WiSE Technology, Wireless Stimulation Endocardially, SOLVE-CRT study

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional cardiac resynchronization therapy (CRT) in heart failure patients. Graphic courtesy of Business Wire.

News | Cardiac Resynchronization Therapy Devices (CRT)| September 15, 2016
EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption...
Sponsored Content | Videos | Heart Failure| September 02, 2016
The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by res
Respicardia, Remede, pacemaker for sleep apnea, central sleep apnea treatment

The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with central sleep apnea.

News | Heart Failure| September 02, 2016
September 2, 2016 — Results from an international, randomized study show that an implanted nerve stimulator significa
News | Cardiac Resynchronization Therapy Devices (CRT)| August 30, 2016
August 30, 2016 — Medtronic plc announced results from the...
Medtronic, Micra TPS pacemaker, transcatheter pacing system, global clinical trial, one-year results, ESC 2016
News | Pacemakers| August 29, 2016
August 29, 2016 — Medtronic plc announced new long-term results from the Medtronic Micra Transcatheter Pacing System
Merlin, Merlin@home, SJM, St. Jude Medical Merlin, cybersecurity

St. Jude Medical said recent claims of the cyber attack vulnerability of its [email protected] remote monitoring system and its implantable EP devices are not true.

Feature | EP Lab| August 29, 2016 | Dave Fornell
August 29, 2016 — Investment research firm Muddy Waters Capital released a report Aug. 25 saying it believes St.
Overlay Init